☰ Accessibility
September 19, 2025

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, announced that its biosimilar Yesafili (aflibercept) has been included under Ontario’s public insurance system in Canada, improving access for patients with serious retinal disorders. Broader Access Through Public Coverage The funding applies to both vial and prefilled syringe presentations…